Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 954 in its research report dated December 06, 2021.

Buy Eris Lifesciences; target of Rs 666: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 666 in its research report dated January 28, 2021.

Buy Eris Lifesciences; target of Rs 671: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 671 in its research report dated November 03, 2020.

Buy Eris Lifesciences; target of Rs 576: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 576 in its research report dated August 05, 2020.

Accumulate Eris Lifesciences; target of Rs 576: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 576 in its research report dated Jun 03, 2020.

Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated November 07, 2019.

Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated July 29, 2019.

Accumulate Eris Lifesciences; target of Rs 695: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 695 in its research report dated January 29, 2019.

Accumulate Eris Lifesciences; target of Rs 704: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 704 in its research report dated November 05, 2018.

Accumulate Eris Lifesciences; target of Rs 885: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 885 in its research report dated May 28, 2018.

Buy Eris Lifesciences; target of Rs 686: Bonanza

Bonanza is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 686 in its research report dated October 26, 2017.

Buy Eris Lifesciences; target of Rs 730: Axis Direct

Axis Direct is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 730 in its research report dated 23 August 2017.

Is Eris Lifesciences the correct prescription for you?

With a predominant focus on the domestic formulations market, a robust portfolio of largely prescription-based drugs, and a tilt towards a promising chronic portfolio, the company seems fundamentally strong.